Approximately 44% of patients with familial platelet disorders that are predisposed to hematologic malignancies caused by autosomal dominant RUNX1 mutations progressed to acute myeloid leukemia caused by second-hit mutations in CDC25C or other genes [16–18]. The gene discussed is RUNX1; the disease is hematologic disorder.